Application of neutralizing antibodies against NI-35/250 myelin-associated neurite growth inhibitory proteins to the adult rat cerebellum induces sprouting of uninjured purkinje cell axons.
The myelin-associated proteins NI-35/250 exert a powerful inhibition on axon regeneration, but their function exerted on intact neurons is still unclear. In the adult CNS these proteins are thought to regulate axon growth processes to confine plasticity within restricted regions and to prevent the formation of aberrant connections. We have recently shown that application of neutralizing IN-1 antibody Fab fragment against NI-35/250 proteins to the adult cerebellum induces the expression of injury/growth-associated markers in intact Purkinje cells. Here, we asked whether these cellular modifications are accompanied by growth phenomena of Purkinje neurites. A single intraparenchymal application of IN-1 Fab fragment to the adult cerebellum induces a profuse sprouting of Purkinje axons along their intracortical course. The newly formed processes spread to cover most of the granular layer depth. A significant axon outgrowth is evident 2 d after injection; it tends to increase at 5 and 7 d, but it is almost completely reversed after 1 month. No axonal modifications occur in control Fab-treated cerebella. The IN-1 Fab fragment-induced cellular changes and axon remodeling are essentially reproduced by applying affinity-purified antibody 472 raised against a peptide sequence of the recombinant protein NI-220, thus confirming the specificity of the applied treatments on these myelin-associated molecules. Functional neutralization of NI-35/250 proteins induces outgrowth from uninjured Purkinje neurites in the adult cerebellum. Together with previous observations, this suggests that these molecules regulate axonal plasticity to maintain the proper targeting of terminal arbors within specific gray matter regions.
Buffo
A
A
Department of Neuroscience and "Rita Levi Montalcini Center for Brain Repair," University of Turin, I-10125 Turin, Italy.
Zagrebelsky
M
M
Huber
A B
AB
Skerra
A
A
Schwab
M E
ME
Strata
P
P
Rossi
F
F
D000367:Age Factors; D000818:Animals; D000906:Antibodies / Q000494:pharmacology; D001369:Axons / Q000737:chemistry / Q000502:physiology; D006131:Growth Inhibitors / Q000276:immunology*; D007127:Immunoglobulin Constant Regions; D009185:Myelin Proteins / Q000276:immunology*; D009416:Nerve Regeneration / Q000276:immunology*; D016501:Neurites / Q000737:chemistry / Q000502:physiology*; D009473:Neuronal Plasticity / Q000502:physiology; D009500:Neutralization Tests; D000070798:Nogo Proteins; D011689:Purkinje Cells / Q000502:physiology* / Q000648:ultrastructure; D051381:Rats; D017208:Rats, Wistar; D011994:Recombinant Proteins / Q000276:immunology
D000906:Antibodies; D006131:Growth Inhibitors; D007127:Immunoglobulin Constant Regions; D009185:Myelin Proteins; D000070798:Nogo Proteins; D011994:Recombinant Proteins; C000603197:Rtn4 protein, rat